Cargando…

Integrated Osteoporosis Care to Reduce Denosumab-Associated Hypocalcemia for Patients with Advanced Chronic Kidney Disease and End-Stage Renal Disease

The incidence of hypocalcemia is high in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) undergoing denosumab treatment. Since 2018, we have carried out a “multidisciplinary integrated care program for osteoporosis among patients with CKD and ESRD” in our hospital. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsu, Chia-Tien, Deng, Ya-Lian, Chung, Mu-Chi, Tsai, Shang-Feng, Lin, Shih-Yi, Chen, Cheng-Hsu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914883/ https://www.ncbi.nlm.nih.gov/pubmed/36766888 http://dx.doi.org/10.3390/healthcare11030313

Ejemplares similares

High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis
por: Ishikawa, Koji, et al.
Publicado: (2016)

Severe Refractory Hypocalcemia Caused by Denosumab
por: Dadana, Sriharsha, et al.
Publicado: (2023)

Prolonged Hypocalcemia After a Single Dose of Denosumab in Chronic Kidney Disease
por: Puar, Akshan, et al.
Publicado: (2021)

Severe Hypocalcemia due to Denosumab in Metastatic Prostate Cancer
por: Muqeet Adnan, Mohammed, et al.
Publicado: (2014)

The Calcium Culprit: A Case of Denosumab-induced Hypocalcemia
por: Kalayanamitra, Ricci, et al.
Publicado: (2019)

Severe hypocalcemia following a single injection of denosumab in a patient with renal impairment
por: Talreja, Draupadi B.
Publicado: (2012)

Denosumab Induced Severe Prolonged Hypocalcemia in Metastatic Prostate Cancer
por: Mehmood, Hassan, et al.
Publicado: (2021)

The Risk of Peripheral Arterial Disease after Parathyroidectomy in Patients with End-Stage Renal Disease
por: Hsu, Yueh-Han, et al.
Publicado: (2016)

Comparison of the Effects of Denosumab and Alendronate on Cardiovascular and Renal Outcomes in Osteoporotic Patients
por: Hsu, Tsuen-Wei, et al.
Publicado: (2019)

Efficacy of Denosumab for Osteoporosis in Patients with Rheumatic Diseases
por: Kaneko, Kaichi, et al.
Publicado: (2022)

Persistent hypocalcemia and hungry bone syndrome after parathyroidectomy and renal transplantation in a patient with end-stage renal disease
por: Tayyebi-Khosroshahi, Hamid, et al.
Publicado: (2017)

Severe Hypocalcemia and Hypomagnesemia with Denosumab in Advanced Chronic Kidney Disease: Case Report and Literature Review
por: Marlow, Christina F., et al.
Publicado: (2018)

Correction: The Risk of Peripheral Arterial Disease after Parathyroidectomy in Patients with End-Stage Renal Disease
por: Hsu, Yueh-Han, et al.
Publicado: (2016)

High bone turnover status as a risk factor in symptomatic hypocalcemia following denosumab treatment in a male patient with osteoporosis
por: Ishikawa, Koji, et al.
Publicado: (2018)

Denosumab for the treatment of osteoporosis
por: McClung, Michael R.
Publicado: (2017)

Severe, Symptomatic Hypocalcemia due to Denosumab Administration: Treatment and Clinical Course
por: Strickling, Jarred, et al.
Publicado: (2019)

Denosumab-Induced Hypocalcemia after Billroth II Gastric Bypass Surgery
por: Schmucker, Abigail M., et al.
Publicado: (2020)

Hypocalcemia in a Patient With Metastatic Prostate Cancer From Denosumab Treatment
por: Gouli, Sugam, et al.
Publicado: (2021)

Denosumab-induced hypocalcemia in a patient with hyperthyroidism: a case report
por: Park, S.Y., et al.
Publicado: (2021)

Denosumab Induced Severe Hypocalcemia in a Patient With Metastatic Prostate Cancer
por: Naher, Kamrun, et al.
Publicado: (2021)

Severe hypocalcemia after denosumab administration in a patient with chronic kidney disease: a case report
por: Kouroglou, Eleni, et al.
Publicado: (2023)

Diagnosis and Management of Denosumab-Induced Hypocalcemia and Hypophosphatemia in the Setting of Metastatic Prostate Cancer
por: Flood, Michael G, et al.
Publicado: (2022)

OA11 Osteoporosis, denosumab, and hypocalcaemia in multimorbid renal impairment
por: Daurat, Jean-Luc, et al.
Publicado: (2023)

Survey of Torus Palatinus in Patients with End-Stage Renal Disease Undergoing Hemodialysis
por: Tai, Shao-Yu, et al.
Publicado: (2018)

Efficacy of Denosumab for Osteoporosis in Two Patients with Adult-Onset Still’s Disease—Denosumab Efficacy in Osteoporotic Still’s Disease Patients
por: Kumaki, Daiki, et al.
Publicado: (2018)

Effects of denosumab treatment in chronic liver disease patients with osteoporosis
por: Saeki, Chisato, et al.
Publicado: (2020)

High Risk of Peritonsillar Abscess in End-Stage Renal Disease Patients: A Nationwide Real-World Cohort Study
por: Chang, Geng-He, et al.
Publicado: (2021)

Osteoporosis in men: epidemiology and treatment with denosumab
por: Sidlauskas, Kristel M, et al.
Publicado: (2014)

A review of denosumab for the treatment of osteoporosis
por: Miyazaki, Tsuyoshi, et al.
Publicado: (2014)

Microvascular Dynamics and Hemodialysis Response of Patients With End-Stage Renal Disease
por: Lee, Jen-Shih, et al.
Publicado: (2022)

End-stage renal disease: a risk factor of deep neck infection – a nationwide follow-up study in Taiwan
por: Chang, Geng-He, et al.
Publicado: (2017)

Reduced Stroke Risk After Parathyroidectomy in End-Stage Renal Disease: A 13-Year Population-Based Cohort Study
por: Hsu, Yueh-Han, et al.
Publicado: (2015)

Primary prevention of atrial fibrillation with beta-blockers in patients with end-stage renal disease undergoing dialysis
por: Lin, Ting-Tse, et al.
Publicado: (2015)

End-stage renal disease preceded by rapid declines in kidney function: a case series
por: Lee, Peter, et al.
Publicado: (2011)

End-stage renal disease as a risk factor for epiglottitis: a population-based cohort study in Taiwan
por: Tsai, Yao-Te, et al.
Publicado: (2020)

Effect of denosumab on renal function in women with osteoporosis evaluated using cystatin C
por: Ohishi, Tsuyoshi, et al.
Publicado: (2022)

Appraisal of lung cancer survival in patients with end-stage renal disease
por: Lu, Ming-Shian, et al.
Publicado: (2019)

Experience With Anti-Sclerostin Antibody for Osteoporosis Patient With End-Stage Renal Disease on Hemodialysis
por: Mukaddam, Mona Al, et al.
Publicado: (2021)

Prevalence and Risk Factors of Osteoporosis in Saudi End-Stage Renal Disease Patients on Hemodialysis
por: Mahzari, Moeber M., et al.
Publicado: (2022)

Hyperuricemia and diabetes mellitus when occurred together have higher risks than alone on all-cause mortality and end-stage renal disease in patients with chronic kidney disease
por: Li, Cheng-Hung, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ibdf43rtfo6qrbifhcufspgqt4